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Abstract
In the analysis of time-to-event data with multiple causes using a com-
peting risks Cox model, often the cause of failure is unknown for some of the
cases. The probability of a missing cause is typically assumed to be indepen-
dent of the cause given the time of the event and covariates measured before
the event occurred. In practice, however, the underlying missing-at-random
assumption does not necessarily hold. Motivated by colorectal cancer sub-
type analysis, we develop semiparametric methods to conduct valid analy-
sis, first when additional auxiliary variables are available for cases only. We
consider a weaker missing-at-random assumption, with missing pattern de-
pending on the observed quantities, which include the auxiliary covariates.
Overlooking these covariates will potentially result in biased estimates. We
use an informative likelihood approach that will yield consistent estimates
even when the underlying model for missing cause of failure is misspecified.
We then consider a method to conduct valid statistical analysis when there
are no auxiliary covariates in the not missing-at-random scenario. The su-
periority of our methods in finite samples is demonstrated by simulation
study results. We illustrate the use of our method in an analysis of colorec-
tal cancer data from the Nurses’ Health Study cohort, where, apparently,
the traditional missing-at-random assumption fails to hold for particular
molecular subtypes.
‡danielnevo@gmail.com
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1 Introduction
Disease heterogeneity is commonly represented by molecular subtyping of the dis-
ease. When considering time-to-disease diagnosis data, each of the disease sub-
types can be considered as a cause for the event of interest, the disease. Those
subtypes, typically defined by biomarkers, are used for better understanding of
biological mechanisms behind the disease. More recently, scientists have found
that influences of disease risk factors can vary across disease subtypes in molecu-
lar pathological epidemiology (MPE) research [Ogino et al., 2016]. For example,
the effect of some life-style factors on the risk of colorectal cancer (CRC) is dif-
ferent across CRC subtypes [Ogino and Stampfer, 2010, Campbell et al., 2010].
Statistical methodology has been developed to evaluate this type of etiologic het-
erogeneity across disease subtypes [Chatterjee et al., 2010, Begg et al., 2013, Wang
et al., 2016, Nevo et al., 2016].
However, subtype data are often missing for some of the disease cases due
to various reasons. For tumor tissue data, for example, biomarkers defining the
tumor subtypes may be missing because tumor tissue is unavailable, or because
collected tumor tissue is insufficient in quantity of quality. One commonly-used
approach for covariates effect estimation in the proportional hazard (PH) compet-
ing risks models with missing cause of failure, originally suggested by Goetghebeur
and Ryan [1995], is to construct estimating equations emerging from two separate
partial likelihoods [Goetghebeur and Ryan, 1995, Dewanji, 1992]. These two par-
tial likelihood approaches were compared and carefully studied by Lu and Tsiatis
[2005]. More recently, Chatterjee et al. [2010] suggested a two-stage model for the
scenario where a large number of subtypes are composed from multiple markers,
and generalized the estimating equation method of Goetghebeur and Ryan [1995]
to estimate regression parameters under their two-stage model.
For this missing cause of failure problem, other methods developed include
parametric methods [Flehinger et al., 2002], Bayesian methods [Basu et al., 2003,
Sen et al., 2010], as well as implementation of commonly used missing data
methodology, such as multiple imputation [Lu and Tsiatis, 2001], utilization of
the EM algorithm [Craiu and Duchesne, 2004, Craiu and Reiser, 2006], and in-
verse probability weighting (IPW) approach [Gao and Tsiatis, 2005, Hyun et al.,
2012]. Most of the aforementioned methods assume a missing-at-random (MAR)
assumption that, given the event time and the covariates measured for all subjects,
including subjects with and without the disease of interest, the probability of a
missing cause is the same for all cases.
Often, the MAR assumption is invalid in applications. For example, it is possi-
ble that data on biomarkers, and therefore subtypes, are more likely to be missing
when a tumor exhibits certain characteristics. In our motivating example, where
of interest are the effects of risk factors on CRC subtypes microsatellite instability
(MSI) and microsatellite stability (MSS) [Cancer Genome Atlas Network, 2012,
Kocarnik et al., 2015], the MSI/MSS status is missing for more than half of the
cases. Our data analysis suggested that CRC tumor location (proximal colon,
distal colon or rectum), which is measured for all cases we considered, may be in-
dicative of the existence of adequate tumor tissue for obtaining the subtype data.
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Furthermore, it is well established in the subject-matter literature that CRC tu-
mor location is associated with MSI/MSS status [Colussi et al., 2013]. In short,
one goal of this paper is to provide methodology taking advantage of the infor-
mation about missingness contained in some disease characteristics (for example,
tumor location in our motivating example). When we do not have information
about disease characteristics that are associated with the missingness status, we
will also propose a method that does not require the MAR assumption; this is
the second goal of the paper. While there exist methods that do not require
MAR, they typically assume the missing status does not depend on event time or
covariates [e.g., Flehinger et al., 2002].
The rest of the paper is organized as follows. In Section 2, we present PH
models for competing risks, allowing for missing subtypes, and discuss various
assumptions concerning the missingness pattern. In Section 3, we describe our
approach in the presence of auxiliary case covariates which is valid under a weaker
MAR assumption. In Section 4, we present a method allowing for not missing-at-
random (NMAR) subtype data. Finite sample properties of the suggested methods
are investigated using simulations in Section 5. Analysis of our motivating exam-
ple, the CRC subtype data, is presented in Section 6. Concluding remarks are
given in Section 7.
2 Models and notations
We consider time-to-event data within the competing risks framework. Let T˜
be the time until the occurrence of the disease and Y be the subtype. Y takes
a single value from {1, ..., K}. Denote also X = X(t) for a vector of possibly
time-dependent covariates. A Cox-type model for the subtype-specific hazard is
then
λk(t) := lim
∆t→0
1
∆t
P (t ≤ T˜ < t+∆t, Y = k|T˜ ≥ t,X = x) = λ01(t)αk(t;η) exp(βTkx)
(1)
with λ01(t) being an unspecified baseline hazard function for subtype 1 and where
αk(t;η) = λ0k(t)/λ01(t), k = 1, ..., K, are baseline hazard ratio functions; α1(t) = 1
by definition. This model allows an unspecified baseline hazards, as in the usual
Cox model [Cox, 1972], while allowing the baseline hazard ratio between two
subtypes to depend on t, possibly via a parametric model. If the number of
different subtypes is not too large, a possible approach is to specify a piecewise
constant function for αk(t;η), for each k. While we operate under the commonly
used proportional hazard model, the methodology we present can be extended to
a broader set of regression functions. Let C be the censoring time, T = min(T˜ , C),
the observed time, and δ = I{T = T˜}, the disease censoring indicator. We assume
that given covariates, censoring time is independent of both T˜ and Y [Kalbfleisch
and Prentice, 2011].
The model described above is extended to allow missing subtype data by in-
troducing an indicator O that equals to one if the subtype Y is observed, and zero
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otherwise. If δ = 0, then O = 0 as well. Denote
pi(t,x, k) := P (O = 1|T˜ = t,X = x, Y = k) (2)
for the probability of observing the subtype given a diagnosis at time t, for a
subject with a covariates vector x and subtype k. Goetghebeur and Ryan [1995]
considered a model where the missing subtype probability depends on the event
time (T˜ ) only. That is, pi(t,x, k) = pi(t) = P (O = 1|T˜ = t). This is a form of
a MAR assumption that we denote by MART . Similarly, we denote MART,X for
the commonly used assumption pi(t,x, k) = pi(t,x) = P (O = 1|T˜ = t,X = x).
We also denote pi = 1− pi as the probability of a missing subtype.
Often, in practice, subtypes (i.e., causes) are more likely to be missing when
the disease exhibits specific characteristics which are associated with the subtypes,
even after controlling for X and T˜ . In these situations, the missingness probabil-
ity depends on the subtype even after controlling for X and T˜ ; that is, neither
MART,X nor MART are expected to hold. However, often, it is reasonable to
assume that the missing probability is independent of the subtype status when
conditioning on these disease characteristics mentioned above in addition to X
and T˜ ; this is a weaker assumption than MART,X and MART . We denote by Q
the vector of measured disease characteristics, which we assume is available for all
cases, and we denote its joint probability function by
νk(q,x, t;ψ) = Pψk(Q = q|Y = k,X = x, T˜ = t),
with ψk being an unknown vector of parameters. In practice, Q might be condi-
tionally independent of either T , X or both, given Y . Note that Q may include
both discrete and continuous variables. It can also be a single random variable, as
in the example presented in Section 6. In that example, Q is the tumor location
and it is possibly associated with the probability of missing CRC subtype; see
Section 6.
To account for Q effect on the possibility of missing subtype, the probability
of observing the subtype, previously defined in (2), is redefined as
pi(t,x, q, k) := P (O = 1|T˜ = t, Y = k,X = x,Q = q), (3)
which is written as pi(t,x, q, k;γ) when a model with a vector of parameters γ
is assumed. We can now introduce more relevant possible assumptions regarding
the missing mechanism:
pi(t,x, q, k) = pi(t,x, q) = P (O = 1|T˜ = t,X = x,Q = q), (MART,X,Q)
pi(t,x, q, k) = pi(q) = P (O = 1|T˜ = t,Q = q). (MARQ)
Clearly, MART,X,Q is a weaker assumption than MART,X . While subject-matter
knowledge can help to determine which missing assumption is reasonable in a
specific application, these assumptions cannot be tested using the observed data,
as often the case when dealing with assumptions regarding missing data.
When using the existing methods, described in Section 1, the validity of anal-
ysis conducted relies on correctness of the MART,X assumption as well as on
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accurate specification of the parametric model pi(t,x;γ). Our methodology, pre-
sented in the next section, alleviate these concerns while replacing them with a
assumptions on the conditional distribution of Q given Y, T˜ and X.
3 Estimation and inference under weaker MAR
We now move to construction of a partial likelihood for estimation of the model
parameters η = {η1, ...,ηk},ψ = {ψ1, ...,ψK} and β = {β1, ...,βk}, although β
is of our main concern. Under MART,X,Q, we may now write (for all t,x and q)
lim
∆t↓0
P (t ≤ T˜ < t+ ∆t, Y = k,Q = q, O = 1|T˜ ≥ t,X = x)
= P (O = 1|T˜ = t,X = x,Q = q)× P (Q = q|Y = k, T˜ = t,X = x, )
× lim
∆t↓0
P (t ≤ T˜ < t+ ∆t, Y = k|T˜ ≥ t,X = x)
= pi(t,x, q)νk(q,x, t;ψ)λ01(t)αk(t;η) exp(β
T
kx) (4)
if the subtype Y is observed, and
lim
∆t↓0
P (t ≤ T˜ < t+ ∆t,Q = q, O = 0|T˜ ≥ t,X = x)
=
K∑
k=1
lim
∆t↓0
P (t ≤ T˜ < t+ ∆t, Y = k,Q = q, O = 0|T˜ ≥ t,X = x)
=
K∑
k=1
pi(t,x, q)νk(q,x, t;ψ)λ01(t)αk(t;η) exp(β
T
kx) (5)
if the subtype is not observed.
Construction of partial likelihood for the PH competing risks model with miss-
ing subtypes for part of the cases entails some complexity. To present existing
methods, we first consider the situation where Q is not observed and is not part
of the model. For the PH competing risks model, the standard approach when
subtypes are observed for all cases is to condition not only on the case occurrence,
as in the standard Cox model with a single type of event, but also on its subtype.
Then, in a model without Q, the baseline hazard in the denominator and the
numerator cancel out, pii = 1 for all i, and the resulting partial likelihood for β is
L(β) =
n∏
i=1
[
exp(βTyixi)∑n
j=1 ξj(ti) exp(β
T
yi
xj)
]I{δi=1}
[Prentice et al., 1978], where ξj(t) equals to one if j is in the risk set at time t and
zero otherwise and yi is the observed subtype.
When subtypes are unobserved for some cases, two partial likelihood ap-
proaches, which differ in the conditioned event, have been discussed, typically
under MART,X , or stronger assumptions. The first [Goetghebeur and Ryan, 1995]
is to condition on the occurrence of an event, the observed subtype and on the fact
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that subtype was observed, and for events with unobserved subtypes, to condition
on the occurrence of an event and on not observing the corresponding subtype.
This is done by considering the hazard at time t of event occurrence of any sub-
type, which is the sum of the hazard functions for all subtypes, also at time t.
That is,
P (t ≤ T˜ < t+ ∆t|T˜ ≥ t,X = x) =
K∑
k=1
P (t ≤ T˜ < t+ ∆t, Y = k|T˜ ≥ t,X = x).
Then, incorporating the missingness model under MART,X and by using calcula-
tions similar to (4) and (5), this likelihood [Goetghebeur and Ryan, 1995] becomes
L(β,η,γ) =

n∏
i=1
[
pi(ti,xi;γ) exp(β
T
yi
xi)∑n
j=1 ξj(ti)pi(ti,xj;γ) exp(β
T
yi
xj)
]I{δi=1,Oi=1}
×
[
pi(ti,xj;γ)
∑K
k=1 exp(β
T
kxi)∑n
j=1 ξj(ti)pi(ti,xj;γ)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=1,Oi=0} .
(6)
However, when MART,X does not hold, this likelihood cannot be used under the
weaker MART,X,Q assumption since pi could not be calculated even when Q is
observed. This is because pi could not be calculated without knowing the value of
Q for subjects in the risk set with δ = 0.
We now construct a more informative partial likelihood, similar to the one
suggested by Dewanji [1992]. We condition on the fact that event was observed,
but not on the event subtype. Taking this approach, we can write down the
partial likelihood for the observed data (Ti, δi,X i, YiOi, Oi,Qiδi). For censored
observations, Oi is defined as zero and Yi andQi are taken to be missing. Following
(1),(4) and (5) and assuming MART,X,Q, we have
L?Q(γ,β,η,ψ) =
n∏
i=1

[
pi(ti,xi, qi;γ)νyi(q,x, t;ψ)αyi(ti;η) exp(β
T
yi
xi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=Oi=1}
×
[∑K
k=1 pi(ti,xi, qi;γ)νk(q,x, t;ψ)αk(ti;η) exp(β
T
kxi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=1,Oi=0} .
(7)
Note that when using L?Q, the missing model need not to be correctly specified,
as long as at least MART,X,Q holds. This is because we can decompose L
?
Q into
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L?Q1 × L?Q2, where
L?Q1(γ) =
n∏
i=1
[
(pi(ti,xi, qi;γ))
I{δi=Oi=1}pi(ti,xi, qi;γ)
I{δi=1,Oi=0}] ,
L?Q2(β,η) =
n∏
i=1

[
νyi(q,x, t;ψ)αyi(ti;η) exp(β
T
yi
xi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=Oi=1}
×
[∑K
k=1 νk(q,x, t;ψ)αk(ti;η) exp(β
T
kxi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=1,Oi=0} .
(8)
Estimation of β can be done based solely on L?Q2. The approach of Goetghebeur
and Ryan [1995], which is also utilized in Chatterjee et al. [2010], is to combine the
score function for β from L in (6) and the score function for η from a likelihood
L?, a likelihood analogue of L?Q in (7) for a model without Q, to form a system
of estimating equations. However, as we noted before, L cannot be used when
the missing probability depends on Q. It is worth mentioning that νk(q,x, t;ψ)
cannot be estimated from the observed subtype data only since, if O and Q are
conditionally dependent,
νk(q,x, t;ψ) = P (Q|X, T ;ψ) 6= P (Q|O = 1,X, T ;ψ,γ).
Let θ = (β,η,ψ) and let θ0 be its true value. We suggest to estimate θ by
maximizing L?Q2 (or `
?
Q2 = logL
?
Q2). This could be done using a standard Newton-
Raphson algorithm. Denote θˆ for the estimated vector of parameters. It can be
shown that θˆ is a consistent estimator. Furthermore,
√
n(θˆ − θ0) converges in
distribution to a multivariate normal distribution with a covariance matrix that
can be consistently estimated by a robust sandwich estimator. Details and proofs
are given in Web Appendix A.
The MART,X,Q assumption used for our method above is weaker than the often
assumed MART,X . While it should be feasible to collect additional data on cases
only, finding Q such that MART,X,Q exactly holds might be impossible in many
applications. Even when both MART,X and MART,X,Q fail, one may expect that
as long as Q and Y are associated conditionally on T and X, using our method
would produce results less biased than those obtained by analysis under MART,X ,
as Q contains information about the unobserved value of Y . The results of our
simulations in Section 5 considering the scenario under NMAR provide evidence to
this claim. In the next section, we present a method which is valid under NMAR,
that can be used if there is no relevant Q available.
4 Estimation and inference under NMAR
In this section we consider the scenario where a Q cannot be found such that
MART,X,Q holds. The subtypes are considered to be NMAR, that is, none of the
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standard MAR assumptions holds, and the probability of missing subtype does
depend on the true subtype status. Similarly to (4) and (5), we may write
lim
∆t↓0
P (t ≤ T˜ < t+∆t, Y = k,O = 1|T˜ ≥ t,X = x) = pi(t,x, k)λ01(t)αk(t;η) exp(βTkx)
if the subtype Y is observed, and
lim
∆t↓0
P (t ≤ T˜ < t+ ∆t, O = 0|T˜ ≥ t,X = x) =
K∑
k=1
pi(t,x, k)λ01(t)αk(t;η) exp(β
T
kx)
if the subtype is not observed. Similarly to the way we formed L?Q, we may write
the partial likelihood obtained by conditioning on the event occurrence but not
on its subtype. This leads to
L?Y (γ,β,η) =
n∏
i=1

[
pi(ti,xi, yi;γ)αyi(ti;η) exp(β
T
yi
xi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=Oi=1}
×
[∑K
k=1 pi(ti,xi, k;γ)αk(ti;η) exp(β
T
kxi)∑n
j=1 ξj(ti)
∑K
m=1 αm(ti;η) exp(β
T
mxj)
]I{δi=1,Oi=0} .
(9)
Estimates for {γ,β,η} are obtained by maximizing L?Y . The resulting estimators
are consistent and normally distributed, with a variance that could be consistently
estimated. Unlike L?Q, L
?
Y cannot be partitioned and thus the parameters in
pi(t, x, y;γ) must be estimated. While this method is valid, and could be used
under NMAR, when Q is available it is expected to provide less efficient estimates
comparing with L?Q, as the latter exploits data available for cases with missing
subtypes.
5 Simulation Study
In the simulation study, we considered two possible subtypes. The baseline hazard
for each subtype was of a Weibull distribution, with parameter values chosen such
that the baseline hazard ratio equals to α2(t; η1, η2) = η1t
η2 with η1 ' 0.037 and
η2 = 1. We took X as a single binary covariate with a prevalence of 0.4 and let
the corresponding hazard ratios to be 1.25 and 2 in subtypes 1 and 2, respectively.
Censoring was generated using an exponential distribution with mean 50, with
additional type I censoring at time 90. The above parameter values were chosen
to have a censoring rate of about 70%. We took Q, the auxiliary variable, to be
a single binary variable that we generated according to P (Q = 1|Y = 1) = 0.25
and P (Q = 1|Y = 2) = 0.5.
We first considered the MARQ scenario with a logistic regression model pi(q) =
expit(γ0 + γqq). We considered various values for γ0 and γq determined by our
desired values for P (O = 1|Q = 0) and P (O = 1|Q = 1). In this scenario, we com-
pared between three alternatives. The first was a complete case analysis (CCA),
where cases with unknown subtype were thrown away and a standard competing
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risks model was used. Alternatives were estimates obtained from maximizing L?Q2
in (8) and the estimates obtained under NMAR from maximizing L?Y while assum-
ing the logistic regression model pi(y) = expit(γ˜0 + γ˜yI{y = 2}). Both estimation
methods are theoretically valid if the truth is MARQ; see details in Web Appendix
B.
Summary of 1000 simulation iterations is presented in Table 1 for sample sizes
n = 500, 1000, 10000 with approximately 150, 300, 3000 numbers of cases, respec-
tively. Confidence intervals when using our methods were calculated using the
asymptotic normal distribution where variance estimates taken from a robust sand-
wich estimator, which is given in Web Appendix A. Both our methods showed good
finite sample properties, with minimal bias even for a relatively small sample size,
and desirable coverage rates for the corresponding confidence intervals. Whenever
Q played a significant role in the missing pattern, i.e., when P (O = 1|Q = 0) and
P (O = 1|Q = 1) were well differentiated, standard deviations of our estimators
were higher, where bias was left unchanged. There was a large bias in the esti-
mation by CCA, even when P (O = 1|Q = 1) = P (O = 1|Q = 0) = 0.2. This
is because while the last equality stands, missing completely at random does not,
since P (O = 1|Y = 1) 6= P (O = 1|Y = 2). An efficiency gain is observed for L?Q
comparing to L?Y . This can be explained by the fact L
?
Q using more data than L
?
Y ,
and specifically the data on Q for observations with missing subtype.
We then turned to a more complex missingness model, which involves ef-
fects of X, T , Q and Y . First, we simulated the data under MART,X,Q with
the model pi(t, x, q) = expit(γqq + 0.5x − 0.01I{t > 50}), with values log(γq) ∈
{1, 1.25, 1.75, 2.5, 5}. Larger γq value implies less cases with missing subtypes, and
a more substantial role of Q in determining O. Other than the missing model,
we used the same values as in the previous scenario. In addition to CCA and
our methods, we also considered the estimating equations of Goetghebeur and
Ryan [1995] (GR), which is valid under MART,X . The L
?
Y method now estimates
the parameters under the model pi(t, x, y) = P (O = 1|T˜ = t,X = x, Y = y) =
expit(γ∗yI{y = 2} + γ∗t I{t > 50} + γ∗xx). Note that, since pi(t, x, q, y), defined in
(3), can be written under MART,X,Q as pi(t, x, q, y) = pi(t, x, q = 1)P (Q = 1|T˜ =
t,X = x, Y = y) + pi(t, x, q = 0)P (Q = 0|T˜ = t,X = x, Y = y), the given model
under MART,X,Q with the logit function for pi(t, x, q) typically does not imply the
logistic regression model for P (O = 1|T˜ = t,X = x, Y = y). That is, this L?Y
analysis used a misspecified missing data model for this simulation setup.
As a final scenario, we repeated the aforementioned simulations, but now tak-
ing the missing model assumed by L?Y , expit(γyI{y = 2} − 0.01I{t > 50} +
0.5x), to be the correct model. That is, now γq = 0. We considered log(γy) ∈
{1, 1.25, 1.75, 2.5, 5}.
Table 2 presents the results for both the MART,X,Q and NMAR scenarios for
n = 10, 000. While larger γq or γy values imply less missing subtypes, larger bias
(in absolute value) was observed for estimates obtained by the GR method. For
CCA, the substantial bias in estimation of both parameters was mildly reduced as
γq or γy grew. For MART,X,Q, performance of the L
?
Q2 approach was not affected
by the value of γq. While in this case L
?
Y used a misspecified logistic model for
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the missing, it provides less biased estimates comparing to CCA and GR for most
parameter values. Looking at the results for NMAR, L?Y had minimal bias while
L?Q had small bias for γy < 2.5, and generally lower bias than the bias observed
for CCA and GR. Simulation results for lower sample size n = 1, 000, presented
in Web Appendix C, has shown larger, though moderate, bias for L?Q and L
?
Y , but
these methods remain superior to GR and CCA.
The likelihood suggested by Dewanji [1992] had been criticized for having a
non mean-zero score function for β if αk is misspecified. To investigate this poten-
tial limitation, we considered the L?Q estimator when taking a piecewise constant
function for the baseline hazard ratio αk and the data was generated by the same
model outlined above. The results, presented in Web Appendix C, did not reveal
further bias when using piecewise constant function for the baseline hazard ratio
αk.
6 Colorectal cancer analysis
To illustrate the use of our method, we present in this section an analysis of CRC
data. CRC is regularly classified according to results of molecular studies [Ogino
et al., 2011, Ogino and Stampfer, 2010, Campbell et al., 2010, Kuipers et al.,
2015]. One commonly-used classification is microsatellite instability (MSI) versus
microsatellite stability (MSS). For example, high body mass index (BMI) has been
associated with MSS subtype of CRC tumors but not MSI subtype [Hughes et al.,
2012].
We used the Nurses’ Health Study (NHS) cohort, in which 121,701 female
nurses enrolled in 1976 and since then answered biennial questionnaire regarding
lifestyle and other risk factors. Whenever a new CRC cancer was diagnosed, the
date was recorded as well as basic tumor characteristics, available for all cases
we considered. The tumor location is classified to be proximal colon, distal colon
or rectum. Our analysis included 1,844 CRC cases that were observed, of which
121 MSI cases, 477 MSS cases, and the remaining cases (66%) had missing MSI
status. In total, our data include 114,073 participants, with 2,786,825 person-years
of follow-up. Data on some risk factors were not measured from the beginning of
the study, hence not all of the 121,701 participants were included in the data.
As a preliminary analysis, we considered a logistic regression model for O, the
indicator that MSI status was known, and we examined various covariates. Details
are given in Web Appendix D. As presented in Web Appendix D, missing MSI
status depends on the tumor location, even when including other covariates (X)
and the time of the diagnosis (T ). It was previously established that in CRC,
MSI status and proximal location are associated [Colussi et al., 2013]. Thus, the
traditional MART,X probably does not hold here. We take here Q to be the tumor
location, equals to one for proximal tumors and zero otherwise. Based on subject-
matter considerations, we assume that conditional on MSI status, CRC tumor
location is independent of the time of diagnosis and the measured risk factors.
That is, we let P (Q = 1|Y = k) = expit(ψk), k = 1, 2. We consider the following
risk factors: family history of CRC (binary), BMI (continuous), regular aspirin
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use (binary) and cumulative pack-year of smoking (continuous). To account for
changes in the baseline hazard along the (calendar) years, we used a stratified
version for the baseline hazard ratio α2. The stratified version, presented in detail
in Web Appendix E, is a natural generalization of L?Q given by (7).
Table 9 compares the results between using a CCA with a stratified Cox model
for the subtype-specific hazards, using the 598 cases with known MSI status and
all CRC-free participants, and implementation of our method based on L?Q that
uses data on all 1844 cases and all CRC-free participants. Differences are shown
between the estimates in both methods. For example, for CRC MSI subtype the
log-hazard ratio of aspirin is about 75% larger (in absolute value) when using CCA
comparing to using L?Q. The estimated standard deviations of the L
?
Q-estimates,
calculated using the robust sandwich estimator, are dramatically lower than those
obtained by CCA. Furthermore, the effect of aspirin on the incidence of MSS CRC
that was not significant at 5% level when using CCA is significant when using L?Q.
7 Discussion
Existing methods for subtype analysis often rely on missing-at-random assump-
tions that may fail to hold in practice. Analysis under these assumptions po-
tentially results in biased effect estimates. In this paper, we presented a weaker
missing-at-random assumption which is reasonable when additionally auxiliary co-
variates are measured for all cases. Under this assumption, we have developed an
informative partial likelihood approach which results in consistent and normally
distributed estimators. We also presented a method to conduct analysis when there
are no auxiliary case covariates available and the subtypes are NMAR, which is
even a weaker assumption.
Comparing the two methods we have proposed, using L?Q alleviates the con-
cerns of fitting the missing model pi, but those are replaced with questions re-
garding the model for Q. Valid use of L?Y relies on correct specification of the
missingness model but does not concern the distribution of Q. Furthermore, while
L?Q cannot be used when Q is unavailable, L
?
Y can be used. Our simulation results
suggested that estimates obtained by L?Q are more efficient than those obtained by
L?Y in situations where both methods provide consistent estimates. Finally, both
methods were shown to reduce bias of the estimators of interest comparing to the
traditionally used estimation equations of Goetghebeur and Ryan [1995].
Analysis by L?Q offers additional two advantages. The first is that when the
missing probability is a function of X, T and Y , and the MART,X,Q does not
hold, estimates using L?Q are expected to be less biased than estimates obtained
under traditionally assumed MART,X . Second is that when MART,X holds, no
damage is done by using L?Q, which is still valid. Furthermore, one may expect an
efficiency gain if Q and Y are associated, even if neither Q or Y are associated
with O (conditionally on T and X). Our simulation results in Section 5 under
NMAR and MART,X confirm these claims.
When Q is high-dimensional, modeling the distribution of Q may increase the
total number of model parameters. It worth mentioning that from our point of
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view, ψ, the parameters characterizing the distribution of Q are nuisance param-
eters, and exact correct specification of the joint distribution of Q is not our goal.
Thus, in order to get a low-dimensional vector or even a scalar Q to be used in the
main analysis, a preliminary analysis of Q yielding a working model to summarize
Q into low-dimensional vector (or scalar) h(Q) can be used. For example, one
may apply a principal component analysis or a factor analysis.
When the number of subtypes of interest is relatively small, which is generally
the case, using a piecewise constant function for the baseline hazard ratio αk(t;β)
can be a good alternative to a more restrictive parametric model. If the number
of investigated subtypes is very large, our approach may result in a computational
burden when estimating the large number of parameters. Under the more restric-
tive MART,X , the method suggested by Chatterjee et al. [2010] may serve as a
potential good alternative. In their suggested method, the auxiliary covariates
can be used as an additional biomarker, or “disease trait” in their terminology,
that its crossproduct with other disease traits form the subtypes. From a clinical
point of view, however, biomarkers (such as MSI) are usually used for subtype
definition, while the other characteristics (such as tumor location) are treated as
specific clinical properties of the disease.
Analysis with our approach will result in two major advantages for practition-
ers. First, potential bias will be eliminated. Second, data that are not used today
can be utilized to get more efficient estimates, with better power for hypothesis
testing and narrower confidence intervals as a result of inclusion of cases that had
been left aside so far. Hence our methods can be very useful in the era of MPE
and precision medicine.
8 Software
R code implementing the methods presented in the paper is available on request
from the corresponding author (danielnevo@gmail.com).
9 Supplementary Material
Supplementary material is available online. Web appendices A–E give technical
details and proofs, present additional simulation results and contain more infor-
mation on the CRC data example.
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Table 1: Simulation results for complete case analysis (CCA) and our methods: L?Q under
MARQ and L
?
Y under NMAR. True values for the parameters were β1 = 0.223 = log(1.25)
and β2 = 0.916 = log(2.5). Relative bias (%) and standard deviation (SD) presented for
both methods as well as confidence interval coverage rates (CI-R) for our methods.
P (O = 1|Q) %Missing n = 500 n = 1, 000 n = 10, 000
Q = 0 Q = 1 Subtype CCA L?Q L
?
Y CCA L
?
Q L
?
Y CCA L
?
Q L
?
Y
β1 0.20 0.80 55% Bias(%) 46.65 -7.20 -8.99 58.36 -3.48 -3.90 57.86 -0.58 -0.54
SD 0.51 0.39 0.44 0.35 0.26 0.29 0.11 0.08 0.09
CI-R 0.96 0.94 0.96 0.95 0.95 0.94
0.40 0.80 44% Bias(%) 32.60 -7.46 -10.98 40.43 -5.65 -4.66 43.23 -0.44 -0.73
SD 0.42 0.35 0.38 0.28 0.23 0.25 0.09 0.08 0.08
CI-R 0.96 0.94 0.96 0.95 0.96 0.95
0.80 0.80 20% Bias(%) 13.78 -9.25 -8.86 19.03 -4.90 -3.66 18.29 -3.85 -3.53
SD 0.32 0.31 0.32 0.22 0.21 0.21 0.07 0.07 0.07
CI-R 0.95 0.95 0.95 0.95 0.94 0.94
0.80 0.40 36% Bias(%) 39.53 -4.28 -2.99 43.03 -0.88 0.51 43.05 -0.59 -0.08
SD 0.33 0.32 0.32 0.23 0.22 0.22 0.07 0.07 0.07
CI-R 0.96 0.96 0.96 0.95 0.96 0.96
0.80 0.20 45% Bias(%) 50.00 -6.13 -2.69 55.34 -2.57 -2.37 53.31 -2.58 -2.35
SD 0.35 0.33 0.34 0.25 0.23 0.24 0.08 0.07 0.08
CI-R 0.96 0.96 0.96 0.96 0.94 0.93
β2 0.20 0.80 55% Bias(%) 16.54 0.50 0.26 15.37 -0.57 -0.06 14.93 -0.77 -0.80
SD 0.31 0.25 0.27 0.22 0.18 0.19 0.07 0.06 0.06
CI-R 0.96 0.95 0.95 0.95 0.94 0.94
0.40 0.80 44% Bias(%) 13.61 1.06 0.94 12.87 0.17 0.35 11.26 -0.85 -0.86
SD 0.28 0.23 0.25 0.19 0.16 0.17 0.06 0.05 0.05
CI-R 0.96 0.96 0.96 0.96 0.96 0.95
0.80 0.80 20% Bias(%) 7.55 1.20 1.61 5.71 -0.62 -0.58 5.28 -0.66 -0.65
SD 0.24 0.22 0.23 0.17 0.15 0.16 0.05 0.05 0.05
CI-R 0.95 0.96 0.96 0.96 0.96 0.95
0.80 0.40 36% Bias(%) 12.01 -0.06 0.86 10.85 -1.12 -1.15 11.24 -0.53 -0.50
SD 0.27 0.23 0.24 0.19 0.15 0.16 0.06 0.05 0.05
CI-R 0.96 0.95 0.96 0.96 0.95 0.95
0.80 0.20 45% Bias(%) 16.63 0.49 1.57 14.85 -0.74 -0.30 14.55 -0.54 -0.51
SD 0.32 0.24 0.27 0.21 0.17 0.18 0.07 0.05 0.06
CI-R 0.94 0.94 0.95 0.94 0.94 0.94
16
Table 2: Simulation results for complete case analysis (CCA), estimating equation ap-
proach (GR) and our methods: L?Q and L
?
Y when truth was NMAR. True values for the
parameters were β1 = 0.223 = log(1.25) and β2 = 0.916 = log(2.5). Sample size for each
simulation iteration was 10,000.
(eγq , eγy ) %Missing β1 (true value 0.223) β2 (true value 0.916)
Subtype CCA L?Q L
?
Y GR CCA L
?
Q L
?
Y GR
MART,X,Q
(1,0) 49.5% Bias(%) 122.65 -2.02 -1.37 -1.27 33.06 -0.69 -0.73 -0.63
SD 0.09 0.08 0.08 0.08 0.07 0.05 0.05 0.06
(1.25,0) 47.2% Bias(%) 115.70 -2.28 -0.95 -5.57 30.71 -0.65 0.39 -2.27
SD 0.08 0.07 0.07 0.08 0.07 0.05 0.05 0.07
(1.75,0) 44.1% Bias(%) 108.93 -0.85 2.13 -11.85 27.12 -0.92 1.67 -7.06
SD 0.08 0.07 0.07 0.08 0.06 0.05 0.06 0.07
(2.5,0) 41.0% Bias(%) 98.95 -1.30 4.93 -15.61 23.58 -1.10 2.79 -7.64
SD 0.08 0.07 0.07 0.08 0.06 0.05 0.06 0.06
(5,0) 36.1% Bias(%) 88.04 -0.93 12.20 -21.18 19.02 -0.82 4.68 -9.45
SD 0.08 0.07 0.07 0.08 0.06 0.05 0.06 0.06
NMAR
(0,1) 49.5% Bias(%) 122.41 -1.63 -1.16 -1.04 32.88 -0.79 -0.84 -0.72
SD 0.09 0.07 0.07 0.08 0.07 0.05 0.05 0.07
(0,1.25) 46.1% Bias(%) 117.19 -2.50 -0.13 -6.34 28.07 -3.16 -1.17 -5.40
SD 0.09 0.08 0.08 0.08 0.06 0.05 0.06 0.07
(0,1.75) 41.0% Bias(%) 108.24 -3.99 -1.56 -15.34 22.93 -5.21 -0.47 -9.97
SD 0.09 0.08 0.07 0.08 0.06 0.05 0.05 0.06
(0,2.5) 36.2% Bias(%) 101.96 -1.12 -0.33 -20.44 17.35 -7.49 -0.48 -14.45
SD 0.08 0.08 0.07 0.08 0.06 0.05 0.05 0.06
(0,5) 28.7% Bias(%) 93.74 2.59 -1.28 -31.59 9.44 -10.44 -0.62 -22.55
SD 0.09 0.08 0.07 0.08 0.05 0.04 0.05 0.06
Risk factor analysis of CRC according to MSI status using a complete case analysis
(CCA) and our proposed method L?Q. The examined risk factors are family history of
CRC (Family), BMI, regular aspirin use (Aspirin) and cumulative pack-year of smoking
(SmokePkyr).
CCA L?
βˆ(eβˆ) SˆD(βˆ) p βˆ(eβˆ) SˆD(βˆ) p
MSI
BMI 0.013(1.013) 0.017 0.47 0.012(1.012) 0.015 0.431
Aspirin -0.279(0.757) 0.196 0.15 -0.168(0.845) 0.149 0.26
SmokePkyr 0.013(1.013) 0.003 < 0.001 0.014(1.014) 0.002 < 0.001
Family 0.738(2.091) 0.151 < 0.001 0.605(1.832) 0.137 < 0.001
MSS
BMI 0.026(1.026) 0.008 0.002 0.018(1.018) 0.006 0.001
Aspirin -0.186(0.831) 0.100 0.063 -0.251(0.778) 0.063 < 0.001
SmokePkyr 0.006(1.006) 0.002 0.002 0.007(1.007) 0.001 < 0.001
Family 0.274(1.316) 0.099 0.006 0.200(1.221) 0.072 0.005
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